1. A novel insulin formulation with a more rapid onset of action;Steiner;Diabetologia,2008
2. A novel pH-insulin VIAject has a faster onset of action than lispro;Nosek;Diabetologia,2010
3. Biocompatability of the ultra-rapid insulin VIAject with continuous insulin infusion sets;Flacke;Diabetologia,2010
4. Establishing glycaemic control with continuous subcutaneous insulin infusion in children and adolescents with type 1 diabetes: experience of the PedPump study in 17 countries;Danne;Diabetologia,2008
5. New insulins and the risk of cancer;Danne;Int J Clin Pract,2010